Abstract
Acute autoimmune hemolytic anemia requires rapid stabilization, typically through the administration of high-dose corticosteroids. However, it is important to consider reactivation of latent infection and how immune suppression can interfere with molecular screening tools. In this case report, we present a patient with Rheumatoid Arthritis/Systemic Lupus Erythematosus experiencing severe autoimmune hemolytic anemia complicated by an unknown latent tuberculosis infection.
Reference15 articles.
1. Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013. Public Health Rep. 2017;132(3):366-375. doi:10.1177/0033354917698117
2. Schwartz NG, Price SF, Pratt RH, Langer AJ. Tuberculosis - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(11):286-289. doi:10.15585/mmwr.mm6911a3
3. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. Accessed September 16, 2021. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002152
4. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. European Respiratory Journal. 2007;30(5):945-950. doi:10.1183/09031936.00040007
5. Churchyard G, Kim P, Shah NS, et al. What We Know About Tuberculosis Transmission: An Overview. The Journal of Infectious Diseases. 2017;216(suppl_6):S629-S635. doi:10.1093/infdis/jix362